Moreover, Arjunan et al. [47] reported how insulin growth factor-1 (IGF-1) deficiency, which is evident in metabolic syndrome, results in molecular signaling defects that occur in neurodegenerative disorders such as AD. Here, IGF1 is linked to Alzheimer disease.